January 27, 2022

Septerna

Septerna Launches with $100 Million Series A Financing to Expand the Frontier of GPCR-targeted Medicines using the Native Complex™ Platform

January 20, 2022

Ambys Medicines

Ambys Medicines Appoints Dr. Corinne Foo-Atkins as Chief Strategy Officer

January 12, 2022

insitro

insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts

January 11, 2022

Pliant Therapeutics

Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones

January 10, 2022

Nurix

Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts

Load More

Sign up for weekly portfolio news.